Search
for
Sort by
Research 121–150 of 1000+
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- Covid induced telogen effluvium (CITE): An insight
- Dermatologic Changes in Experimental Model of Long COVID
- Corona With Lyme: A Long COVID Case Study
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Pathological sequelae of long-haul COVID
- Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Neurological post‐acute sequelae of SARS‐CoV‐2 infection
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
- How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Peculiarities of clinical course and diagnostic of alopecia areata with comorbidity. Clinical observations
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
- Long COVID syndrome: An unfolding enigma
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- A narrative review of SARS-CoV-2 variants and long COVID
- Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
- The Multisystem Impact of Long COVID: A Comprehensive Review
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells